Imaging of Neuroendocrine Tumors
Top Cited Papers
- 1 July 2006
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 36 (3), 228-247
- https://doi.org/10.1053/j.semnuclmed.2006.03.007
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- 111In-pentetreotide scintigraphy: procedure guidelines for tumour imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patientsEuropean Journal of Surgical Oncology, 2005
- Does iodine‐131 meta‐iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?Clinical Endocrinology, 2004
- Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomasJournal of Internal Medicine, 2001
- Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumoursNuclear Medicine Communications, 1998
- Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Visualization of the thymus by substance P receptor scintigraphy in manEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- In vivo imaging of chromogranin A-positive endocrine tumours by three-step monoclonal antibody targetingEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumoursEuropean Journal Of Cancer, 1996